The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus

Published:2017-07-17 Issue:12 Volume:18 Page:1179-1186
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Kim Gyuri¹,Oh Sewon¹,Jin Sang-Man¹,Hur Kyu Yeon¹,Kim Jae Hyeon¹,Lee Moon-Kyu¹

Affiliation:

1. Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

Funder

Novartis

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1353080

Reference58 articles.

1. Diabetes: a 21st century challenge

2. Diabetes in Asia

3. Diabetes in Asia

4. IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes

5. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36:1033–1046.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of DPP-4 Inhibitors and Metformin Combinations in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis;Diabetes, Metabolic Syndrome and Obesity;2024-06

2. What is Glycaemic Variability and which Pharmacological Treatment Options are Effective? A Narrative Review;European Endocrinology;2023

3. The Influence of Lifestyle and Treatment on Oxidative Stress and Inflammation in Diabetes;International Journal of Molecular Sciences;2022-12-12

4. Influence of dipeptidyl peptidase-4 inhibitors on glycemic variability in patients with type 2 diabetes: A meta-analysis of randomized controlled trials;Frontiers in Endocrinology;2022-08-09

5. Hypoglycemic agents and glycemic variability in individuals with type 2 diabetes: A systematic review and network meta-analysis;Diabetes and Vascular Disease Research;2022-05